News
Please use one of the following formats to cite this article in your essay, paper or report: APA PhoreMost. (2025, May 12). PhoreMost makes key appointments to Board to advance development of next ...
Cell and gene therapy start-up NKure Therapeutics and international gene-editing company CRISPR Therapeutics have entered into a partnership to co-develop and co-commercialise CTX112 — a next ...
Viking Therapeutics is developing drugs for obesity and non-alcoholic fatty liver disease. The company has no revenue and may have none for several years as it works to get drug approval.
Novartis AG agreed to buy US biotech Regulus Therapeutics Inc. in a deal that could be valued at up to $1.7 billion. The Swiss company will pay $7 a share in cash upfront through a subsidiary ...
Merck KGaA is nearing a deal to acquire SpringWorks Therapeutics Inc., people familiar with the matter said. An announcement may come as soon as Monday, the people said, asking not to be ...
Click Therapeutics has collected a groundbreaking green light from the FDA for the agency’s first prescription digital therapeutic aimed at preventing migraines. Designed to be used alongside ...
CRISPR Therapeutics won its first regulatory approval a little over a year ago, and has compelling candidates in the pipeline. Of course, Vertex's success didn't happen overnight -- and the ...
Piotr Swat / SOPA Images / LightRocket via Getty Images Some studies of Sarepta Therapeutics' muscular dystrophy drug, Elevidys, have been halted by European regulators after a patient taking it died.
Sangamo Therapeutics enters into a license agreement with Eli Lilly. Sangamo will receive an upfront payment of $18 million and is eligible to earn up to $1.4 billion in additional fees and payments.
Sarah Silbiger / Getty Images Shares of Aldeyra Therapeutics slumped nearly 75% to a record low on Thursday. The FDA told the drugmaker in a letter that its drug submitted to treat dry eye disease ...
Max just got a new logo. Again. Two years after rebranding from HBO Max to just Max with new a bright blue-and-white logo, the Warner Bros Discovery-owned streaming service is making an update to ...
PHILADELPHIA, March 31, 2025 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company") today announced that its Board of Directors has approved a revised operating plan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results